Delivery of Radioactive Imaging Agents by Reconstituted High Density Lipoproteins (rHDL). Validation of the rHDL/drug Delivery Model by Nuclear Molecular Imaging

StatusFinished
Effective start/end date1/03/1531/08/16

Funding

  • Intramural Research(UNTHSC): $25,000.00

Keywords

  • Biotechnology & Drug Development, Cancer Research, Nanotechnology, Men's Health, Prostate Cancer